Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 1.30
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.20 (15.385%)
Open: 1.40
High: 1.40
Low: 1.40
Prev. Close: 1.40
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Third Point Investors NAV per share drops by quarter

Wed, 26th Apr 2023 14:43

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

IQ-AI Ltd - Jersey-based medical services firm - Revenue for 2022 is GBP535,886, up 2.8% from GBP521,069 the year prior. Pretax loss is GBP511,601, widening from GBP501,058. Loss per share narrows slightly to 0.28p per share, from a loss of 0.29p a year ago. Says focus is on converting as many of its trial sites to long term customers. Says it does not believe that IQ-AI's current market value is a reflection of the accretion of value over the past five years.

----------

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on the field of surgical endoscopy - Revenue grows 8.0% to GBP27.2 million, from GBP25.2 million in 2021. Says it has "made significant progress in establishing sales channels through new products, as well as the development of our commercial footprint". Pretax loss is GBP31.0 million, widening from GBP30.3 million. declares no dividend, unchanged from a year ago. Chief Executive Craig Gulliford says: "We expect to see the continued acceleration of the commercialisation of our core technology and the introduction of new innovative products, as well as the expansion of our Kamaptive programme as we continue to build a world class medical device and tech licensing company."

----------

M&G Credit Income Investment Trust PLC - debt investment firm - Net asset value per share at December 31 94.99 pence, down 6.4% from 101.44p in at December 31 the year prior due to a widening of credit spreads, rather than interest rate rises. NAV total return of negative 2.8%, swinging from a return of 13%. Declares dividend of 5.35p per share "in spite of the company’s underperformance", increasing 32% from 4.04p a year ago, "to reflect" the confidence of its investment manager. Says it expects a rise in NAV as credit spreads normalise.

----------

Third Point Investors Ltd - feeder fund that invests in the Third Point Offshore Fund - Net asset value per share at December 31 USD24.46, down 24% from USD32.37. Returns negative 24% on NAV total return basis, returns negative 26% on share price basis. Notes that "most all asset classes performed poorly", seeing significant losses in all sectors. "While 2022 was extremely disappointing from a performance perspective, the investment manager is encouraged that the opportunity set currently presented is highly attractive for capitalising on its many strategies employed, including security selection and specialist credit," comments Chair Rupert Dorey.

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
15 Oct 2020 20:27

IN BRIEF: IQ-AI Completes Key New Product Launch With IB Stroke

IN BRIEF: IQ-AI Completes Key New Product Launch With IB Stroke

Read more
8 Oct 2020 19:54

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

Read more
16 Sep 2020 22:16

IN BRIEF: Keck Medical Center Buys IB Clinic From IQ-AI Subsidiary

IN BRIEF: Keck Medical Center Buys IB Clinic From IQ-AI Subsidiary

Read more
4 Sep 2020 15:42

IN BRIEF: IQ-AI Continues Development Of "Gadolinium Free" Imaging

IN BRIEF: IQ-AI Continues Development Of "Gadolinium Free" Imaging

Read more
7 Aug 2020 10:29

IQ-AI Interim Loss Widens As Covid-19 Delays Other Medical Treatments

IQ-AI Interim Loss Widens As Covid-19 Delays Other Medical Treatments

Read more
5 Aug 2020 22:03

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

Read more
27 Jul 2020 20:42

IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track

IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track

Read more
10 Jul 2020 12:05

IN BRIEF: IQ-AI Starts Development Of Cancer Detection Product

IN BRIEF: IQ-AI Starts Development Of Cancer Detection Product

Read more
8 Jun 2020 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Jun 2020 15:54

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

Read more
4 May 2020 11:47

IQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth

IQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth

Read more
20 Jan 2020 12:15

IQ-AI Secures StoneChecker Software Approval In South Korea

IQ-AI Secures StoneChecker Software Approval In South Korea

Read more
9 Jan 2020 11:16

IQ-AI Signs Distribution Agreement For Liver Analysis Technology

IQ-AI Signs Distribution Agreement For Liver Analysis Technology

Read more
9 Jan 2020 09:49

IQ-AI subsidiary subsidiary enters deal over liver disease analysis product

(Sharecast News) - IQ-AI announced on Thursday that its subsidiary Imaging Biometrics (IB) has entered into a global distribution agreement with AI Metrics.

Read more
19 Dec 2019 10:47

IQ-AI To Seek Buyer For Stonechecker Software Following Review

IQ-AI To Seek Buyer For Stonechecker Software Following Review

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.